Teva Pharmaceutical Industries (TEVA) Invested Capital (2009 - 2026)
Teva Pharmaceutical Industries' (TEVA) quarterly Invested Capital came in at $4.5 billion in Q2 2026, up 869.83% YoY from $464.0 million in Q2 2025, and up 72.28% on a QoQ basis from $2.6 billion in Q1 2026.
Teva Pharmaceutical Industries (TEVA) Invested Capital (2009 - 2026) Analysis & Trends
Teva Pharmaceutical Industries (TEVA) has 18 years of Invested Capital data on file, last reported at $4.5 billion in Q2 2026.
- Quarterly Invested Capital rose 869.83% year-over-year to $4.5 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $9.0 billion (up 70.72% YoY) and the FY2025 annual result came in at $1.8 billion, up 2.19% from the prior year.
- Invested Capital advanced to $4.5 billion in Q2 2026, from $2.6 billion in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $4.5 billion in Q2 2026 to a low of $24.0 million in Q3 2025.
- A 5-year average of $1.9 billion and a median of $1.9 billion in 2023 frame the typical range for Invested Capital.
- Annual changes were most pronounced in 2025 — Invested Capital slumped 99.07% — and 2026, when it surged 869.83%.
- Tracing TEVA's Invested Capital over 5 years: stood at $2.1 billion in 2022, then declined by 20.72% to $1.7 billion in 2023, then grew by 6.52% to $1.8 billion in 2024, then advanced by 2.19% to $1.8 billion in 2025, then jumped by 147.25% to $4.5 billion in 2026.
- The last three Invested Capital figures came in at $4.5 billion (Q2 2026), $2.6 billion (Q1 2026), and $1.8 billion (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | 9.90 Bn |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | 4.50 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 3.74 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 1.74 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 73.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 630.00 Mn |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn | 26.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.50 Bn |
| Mar 31, 2026 | 2.61 Bn |
| Dec 31, 2025 | 1.82 Bn |
| Sep 30, 2025 | 24.00 Mn |
| Jun 30, 2025 | 464.00 Mn |
| Mar 31, 2025 | 421.00 Mn |
| Dec 31, 2024 | 1.78 Bn |
| Sep 30, 2024 | 2.58 Bn |
| Jun 30, 2024 | 2.09 Bn |
| Mar 31, 2024 | 3.06 Bn |
| Dec 31, 2023 | 1.67 Bn |
| Sep 30, 2023 | 1.48 Bn |
| Jun 30, 2023 | 1.98 Bn |
| Mar 31, 2023 | 1.02 Bn |
| Dec 31, 2022 | 2.11 Bn |
| Sep 30, 2022 | 2.77 Bn |
| Jun 30, 2022 | 1.72 Bn |
| Mar 31, 2022 | 2.08 Bn |
| Dec 31, 2021 | 1.43 Bn |
| Sep 30, 2021 | 2.71 Bn |